Crossmark

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody

Crossref DOI link: https://doi.org/10.1186/s40824-022-00329-8

Published Online: 2022-12-09

Published Print: 2022-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Hao https://orcid.org/0000-0003-1503-3844
Wei, Guoli

Luo, Lixia

Li, Lingchang

Gao, Yibo

Tan, Xiaobin

Wang, Sen

Chang, Haoxiao

Liu, Yuxi

Wei, Yingjie

Song, Jie https://orcid.org/0000-0002-5685-9741
Zhang, Zhenhai

Huo, Jiege
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81873055)

Jiangsu Province TCM Leading Talent Training project (SLJ0211)

Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province (JD2019SZXYB04)

Six Talent Peaks Project in Jiangsu Province (SWXY-010-2019)

Anhui Provincial Key Research and Development Plan (202104b11020010)

Chuzhou University Scientific research projects (2020qd50)
License Information

Text and Data Mining valid from 2022-09-30

Version of Record valid from 2022-12-09
More Information

Article History

Received: 22 August 2022

Accepted: 22 November 2022

First Online: 9 December 2022

Declarations

:

: All the experimental procedures were carried out in accordance with the ARRIVE Guidelines and the U.K. Animals (Scientifc Procedures) Act, 1986 and associated the National Research Council’s Guide for the Care and Use of Laboratory Animals.

: All authors are consent for publication.

: The authors have no fnancial conficts of interest.

Document is current

Any future updates will be listed below